ArticleInternal and emergency medicine2026
Association between clinical frailty and multidrug-resistant positive cultures in hospitalized older adults.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between clinical frailty and multidrug-resistant positive cultures in hospitalized older adults: comment.Internal and emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frailty is a key determinant of adverse outcomes in older adults. The association between clinical frailty and multidrug-resistant (MDR) positive cultures in hospitalized older adults remains insufficiently defined. Understanding this association may improve early risk stratification and inform infection control strategies in acute care. We conducted a prospective, observational, single-center cohort study in an internal medicine ward. Patients aged ≥ 65 years admitted with clinical suspicion of bacterial infection requiring microbiological testing and antibiotic therapy were eligible. The diagnosis of infection was based on clinical, laboratory, and imaging findings as assessed by the treating physician, regardless of microbiological confirmation. Among 208 eligible patients with confirmed infection, participants were stratified by culture results into negative, non-MDR, and MDR + groups. Frailty was assessed using the Clinical Frailty Scale (CFS) and Primary Care Frailty Index (PC-FI), while comorbidity burden was evaluated with the Cumulative Illness Rating Scale (CIRS). Multinomial logistic regression was used to explore variables associated with MDR-positive culture status. Of the 208 patients, 57% were culture-negative, 29% had non-MDR infections and 14% MDR + . Frailty increased progressively across groups: median CFS was 5, 6, and 6 (p = 0.004), and median PC-FI was 0.20, 0.24, and 0.28 (p = 0.021). The prevalence of frailty rose from 56 to 70% to 83% (CFS > 4; p = 0.015). MDR + patients more frequently required full-time caregiving and had longer hospitalization and antibiotic duration. In multivariable analysis, CFS remained associated with MDR-positive culture status after adjustment for age and comorbidity burden (OR 1.57, 95% CI 1.17-2.11) although residual confounding cannot be excluded. In this selected single-center cohort of hospitalized older adults, clinical frailty was associated with MDR-positive cultures. These findings should be considered hypothesis-generating and should not be interpreted as supporting broader empirical antibiotic therapy based on frailty alone.
Indexed as
Identifiers
42527759What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.